Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
- PMID: 18178610
- DOI: 10.1136/gut.2006.114660
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
Abstract
Because of the increasing use of immunosuppressive and biological drugs, the occurrence of opportunistic infections has become a key safety issue for patients with inflammatory bowel disease (IBD). Consequently, improvement of healthcare workers' knowledge of this domain is urgent. In this review, the preventive measures that would help to reduce the rate of opportunistic infections in patients with IBD are listed, and the management of situations frequently confronting doctors is considered. In the absence of national and international recommendations, the information given here should help doctors to optimise patient outcomes.
Comment in
-
Nitazoxanide for cryptosporidial infection in Crohn's disease.Gut. 2008 Aug;57(8):1179-80. Gut. 2008. PMID: 18628383 No abstract available.
-
Fatal invasive pulmonary aspergillosis associated with adalimumab therapy.Gut. 2009 Jan;58(1):149. doi: 10.1136/gut.2008.161638. Gut. 2009. PMID: 19091839 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources